Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Columbia, Missouri 65212


Purpose:

This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after gastric bypass surgery.


Criteria:

Inclusion Criteria: - Subject is age ≥ 18 years - Patient meets the criteria for laparoscopic gastric bypass surgery - Females only: Patient is willing to take a urine pregnancy test Exclusion Criteria: - Subject allergic to omeprazole or famotidine - Patient receiving antifungal (i.e. ketoconazole or itraconazole) - Hepatic insufficiency - History of Crohns disease - History of Zollinger-Ellison disease - Patient received an investigational drug within 30 days of enrollment - Patient currently enrolled in another research project - Females Only: Pregnancy or plan on becoming pregnant during the next 14 weeks


NCT ID:

NCT00557349


Primary Contact:

Principal Investigator
Roger de la Torre, MD
University of Missouri-Columbia


Backup Contact:

N/A


Location Contact:

Columbia, Missouri 65212
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.